Efficacy of biological disease-modifying antirheumatic drugs: a systematic literature review informing the 2013 update of the EULAR recommendations for the management of rheumatoid arthritis
Year: 2014
Type: review
Study design: Systematic Review
Source: Annals of the Rheumatic Diseases
Institutions: University of Leeds, Chapel Allerton Hospital, Leeds Teaching Hospitals NHS Trust, NIHR Leeds Musculoskeletal Biomedical Research Unit, Amsterdam UMC Location University of Amsterdam, Hospital Garcia de Orta, University of Amsterdam, Centre Hospitalier Universitaire de Nîmes, Université Montpellier 1, Yokohama City University, Hospital Universitario de Valme, Assistance Publique – Hôpitaux de Paris, Pitié-Salpêtrière Hospital, Université Pierre-et-Marie-Curie, Klinik Hietzing, Medical University of Vienna
Language: English
Subfield: Rheumatology
Field: Medicine
Domain: Health Sciences
Keywords: rheumatoid arthritis, biologic DMARDs, infliximab, etanercept, adalimumab, certolizumab pegol, golimumab, anakinra, abatacept, rituximab, tocilizumab, methotrexate combination therapy, treat-to-target, radiographic progression, drug-free remission, dose reduction, early treatment intensification
Open Access status: bronze
OpenAlex ID: W2113633952
